Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$12.42 - $17.29 $3,974 - $5,532
320 Added 0.69%
46,854 $732,000
Q4 2023

Feb 12, 2024

BUY
$11.13 - $15.78 $5,008 - $7,101
450 Added 0.98%
46,534 $695,000
Q3 2023

Nov 13, 2023

BUY
$16.15 - $42.35 $3,714 - $9,740
230 Added 0.5%
46,084 $744,000
Q2 2023

Aug 14, 2023

BUY
$40.29 - $82.51 $27,800 - $56,931
690 Added 1.53%
45,854 $1.9 Million
Q1 2023

May 04, 2023

BUY
$56.44 - $118.81 $18,060 - $38,019
320 Added 0.71%
45,164 $2.72 Million
Q4 2022

Feb 09, 2023

BUY
$63.98 - $85.37 $36,468 - $48,660
570 Added 1.29%
44,844 $3.29 Million
Q3 2022

Nov 08, 2022

BUY
$67.99 - $89.57 $38,754 - $51,054
570 Added 1.3%
44,274 $3.36 Million
Q2 2022

Aug 02, 2022

BUY
$56.6 - $89.9 $339,317 - $538,950
5,995 Added 15.9%
43,704 $3.04 Million
Q1 2022

May 10, 2022

SELL
$60.15 - $84.52 $1.41 Million - $1.98 Million
-23,372 Reduced 38.26%
37,709 $3.12 Million
Q4 2021

Feb 14, 2022

BUY
$75.08 - $121.99 $802,755 - $1.3 Million
10,692 Added 21.22%
61,081 $4.59 Million
Q3 2021

Nov 03, 2021

BUY
$116.17 - $194.55 $810,750 - $1.36 Million
6,979 Added 16.08%
50,389 $5.85 Million
Q2 2021

Aug 13, 2021

BUY
$130.4 - $225.58 $667,648 - $1.15 Million
5,120 Added 13.37%
43,410 $9.63 Million
Q1 2021

May 03, 2021

SELL
$124.11 - $190.17 $8,687 - $13,311
-70 Reduced 0.18%
38,290 $5.06 Million
Q4 2020

Feb 02, 2021

BUY
$112.16 - $174.14 $69,539 - $107,966
620 Added 1.64%
38,360 $6.64 Million
Q3 2020

Nov 04, 2020

SELL
$58.05 - $111.31 $43,537 - $83,482
-750 Reduced 1.95%
37,740 $4.2 Million
Q2 2020

Aug 07, 2020

BUY
$57.2 - $74.41 $2.2 Million - $2.86 Million
38,490 New
38,490 $2.28 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.86B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Treasurer Of The State Of North Carolina Portfolio

Follow Treasurer Of The State Of North Carolina and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

News

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.